78 Research = Rapid Ramp in FDA-Approved AI Medical Devices, per Stanford HAI Note: FY21, FY22 & FY23 USA government budget figures are actuals. FY24 data is enacted but not actual, FY25 data is requested. NIH share of total budget is requested. Source: Nestor Maslej et al., ‘The AI Index 2025 Annual Report,’ AI Index Steering Committee, Stanford HAI (4/25); USA Food & Drug Administration, ‘FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline’ (5/25); NITRD.gov (5/25) New AI-Enabled Medical Devices Approved by USA Food & Drug Administration – 1995-2023, per Stanford HAI & USA FDA Number of AI Medical Devices Approved Education / Government / Research AI Adoption = Rising Priority In a historic first for the [USA FDA], FDA Commissioner Martin A. Makary, M.D., M.P.H., today announced an aggressive timeline to scale use of artificial intelligence (AI) internally across all FDA centers by June 30, 2025… …To reflect the urgency of this effort, Dr. Makary has directed all FDA centers to begin deployment immediately, with the goal of full integration by the end of June. - USA FDA Press Release, 5/25 AI-Enabled Medical Devices Approved New USA FDA AI Policy (5/25) 1 0 1 1 0 0 1 0 0 1 1 0 0 5 0 2 2 3 3 6 6 18 26 64 80 114 129 160 223 0 125 250 1995 1999 2003 2007 2011 2015 2019 2023 Government R&D funding has been a key part of AI development budgets, especially in healthcare: - FY21-FY25 Federal USA AI Budget: $14.7B - FY25 Share Requested by National Institutes of Health: 34%